GSK first-quarter beats estimates on shingles vaccine surge

GlaxoSmithKline Plc reported better-than-expected first-quarter revenue and earnings on Wednesday, as sales of the British drugmaker’s fast-growing shingles vaccine surged another 60 percent.

…read more

Source:: Reuters – Business News


Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.